Cargando…
The Leydig Steroid Cell Tumor in a Postmenopausal Woman with Clinical and Biochemical Hyperandrogenism: A Case Report
Leydig cell tumors (LCTs) refer to tumors of the stroma of the genital strand, which are found mainly in postmenopausal women. The diagnosis of LCTs in postmenopausal women is associated with specific difficulties and is based on the identification of hyperandrogenism with clinical manifestations of...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320079/ https://www.ncbi.nlm.nih.gov/pubmed/35888744 http://dx.doi.org/10.3390/metabo12070620 |
_version_ | 1784755705923764224 |
---|---|
author | Suturina, Larisa V. Sharifulin, Eldar M. Sharifulin, Maharam A. Lazareva, Ludmila M. Danusevich, Irina N. Ievleva, Kseniia D. Nadeliaeva, Iana G. |
author_facet | Suturina, Larisa V. Sharifulin, Eldar M. Sharifulin, Maharam A. Lazareva, Ludmila M. Danusevich, Irina N. Ievleva, Kseniia D. Nadeliaeva, Iana G. |
author_sort | Suturina, Larisa V. |
collection | PubMed |
description | Leydig cell tumors (LCTs) refer to tumors of the stroma of the genital strand, which are found mainly in postmenopausal women. The diagnosis of LCTs in postmenopausal women is associated with specific difficulties and is based on the identification of hyperandrogenism with clinical manifestations of virilization, which has an erased picture in postmenopausal women. LCTs require differential diagnosis with other causes of hyperandrogenism. We present the clinical case of a 55-year-old Russian postmenopausal patient with LCTs of the right ovary, significantly increased levels of androgens, and rapidly progressive clinical signs of hyperandrogenism. The patient underwent laparoscopic bilateral salpingo-oophorectomy, and the androgen indices reached average values by the first and third month after surgery. This case demonstrates that LCTs are often benign with a good prognosis and normalization of the clinical and laboratory manifestations of hyperandrogenism after surgical treatment. The type of surgery performed (bilateral salpingo-oophorectomy rather than unilateral) is recommended as the treatment of choice for LCTs in postmenopausal patients. |
format | Online Article Text |
id | pubmed-9320079 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93200792022-07-27 The Leydig Steroid Cell Tumor in a Postmenopausal Woman with Clinical and Biochemical Hyperandrogenism: A Case Report Suturina, Larisa V. Sharifulin, Eldar M. Sharifulin, Maharam A. Lazareva, Ludmila M. Danusevich, Irina N. Ievleva, Kseniia D. Nadeliaeva, Iana G. Metabolites Case Report Leydig cell tumors (LCTs) refer to tumors of the stroma of the genital strand, which are found mainly in postmenopausal women. The diagnosis of LCTs in postmenopausal women is associated with specific difficulties and is based on the identification of hyperandrogenism with clinical manifestations of virilization, which has an erased picture in postmenopausal women. LCTs require differential diagnosis with other causes of hyperandrogenism. We present the clinical case of a 55-year-old Russian postmenopausal patient with LCTs of the right ovary, significantly increased levels of androgens, and rapidly progressive clinical signs of hyperandrogenism. The patient underwent laparoscopic bilateral salpingo-oophorectomy, and the androgen indices reached average values by the first and third month after surgery. This case demonstrates that LCTs are often benign with a good prognosis and normalization of the clinical and laboratory manifestations of hyperandrogenism after surgical treatment. The type of surgery performed (bilateral salpingo-oophorectomy rather than unilateral) is recommended as the treatment of choice for LCTs in postmenopausal patients. MDPI 2022-07-04 /pmc/articles/PMC9320079/ /pubmed/35888744 http://dx.doi.org/10.3390/metabo12070620 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Case Report Suturina, Larisa V. Sharifulin, Eldar M. Sharifulin, Maharam A. Lazareva, Ludmila M. Danusevich, Irina N. Ievleva, Kseniia D. Nadeliaeva, Iana G. The Leydig Steroid Cell Tumor in a Postmenopausal Woman with Clinical and Biochemical Hyperandrogenism: A Case Report |
title | The Leydig Steroid Cell Tumor in a Postmenopausal Woman with Clinical and Biochemical Hyperandrogenism: A Case Report |
title_full | The Leydig Steroid Cell Tumor in a Postmenopausal Woman with Clinical and Biochemical Hyperandrogenism: A Case Report |
title_fullStr | The Leydig Steroid Cell Tumor in a Postmenopausal Woman with Clinical and Biochemical Hyperandrogenism: A Case Report |
title_full_unstemmed | The Leydig Steroid Cell Tumor in a Postmenopausal Woman with Clinical and Biochemical Hyperandrogenism: A Case Report |
title_short | The Leydig Steroid Cell Tumor in a Postmenopausal Woman with Clinical and Biochemical Hyperandrogenism: A Case Report |
title_sort | leydig steroid cell tumor in a postmenopausal woman with clinical and biochemical hyperandrogenism: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320079/ https://www.ncbi.nlm.nih.gov/pubmed/35888744 http://dx.doi.org/10.3390/metabo12070620 |
work_keys_str_mv | AT suturinalarisav theleydigsteroidcelltumorinapostmenopausalwomanwithclinicalandbiochemicalhyperandrogenismacasereport AT sharifulineldarm theleydigsteroidcelltumorinapostmenopausalwomanwithclinicalandbiochemicalhyperandrogenismacasereport AT sharifulinmaharama theleydigsteroidcelltumorinapostmenopausalwomanwithclinicalandbiochemicalhyperandrogenismacasereport AT lazarevaludmilam theleydigsteroidcelltumorinapostmenopausalwomanwithclinicalandbiochemicalhyperandrogenismacasereport AT danusevichirinan theleydigsteroidcelltumorinapostmenopausalwomanwithclinicalandbiochemicalhyperandrogenismacasereport AT ievlevakseniiad theleydigsteroidcelltumorinapostmenopausalwomanwithclinicalandbiochemicalhyperandrogenismacasereport AT nadeliaevaianag theleydigsteroidcelltumorinapostmenopausalwomanwithclinicalandbiochemicalhyperandrogenismacasereport AT suturinalarisav leydigsteroidcelltumorinapostmenopausalwomanwithclinicalandbiochemicalhyperandrogenismacasereport AT sharifulineldarm leydigsteroidcelltumorinapostmenopausalwomanwithclinicalandbiochemicalhyperandrogenismacasereport AT sharifulinmaharama leydigsteroidcelltumorinapostmenopausalwomanwithclinicalandbiochemicalhyperandrogenismacasereport AT lazarevaludmilam leydigsteroidcelltumorinapostmenopausalwomanwithclinicalandbiochemicalhyperandrogenismacasereport AT danusevichirinan leydigsteroidcelltumorinapostmenopausalwomanwithclinicalandbiochemicalhyperandrogenismacasereport AT ievlevakseniiad leydigsteroidcelltumorinapostmenopausalwomanwithclinicalandbiochemicalhyperandrogenismacasereport AT nadeliaevaianag leydigsteroidcelltumorinapostmenopausalwomanwithclinicalandbiochemicalhyperandrogenismacasereport |